Home monitoring for patients with pulmonary fibrosis
The SUITS Study: Implementation of Home Monitoring in Patients With Pulmonary Fibrosis
This study tests if using home monitoring and video calls can help people with pulmonary fibrosis manage their condition as well as or better than regular clinic visits.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 220 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Erasmus Medical Center Academic / other |
| Locations | 11 sites (Amsterdam and 10 other locations) |
| Trial ID | NCT06883448 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of replacing half of the outpatient clinic visits for pulmonary fibrosis patients with home monitoring and video consultations. Participants will be randomly assigned to either traditional hospital-based care or a home monitoring program that includes weekly health measurements and remote consultations. The home monitoring program features tools like home spirometry, pulse-oximetry, and a mobile health application for tracking patient-reported outcomes. The study will last for 12 months, with questionnaires administered at set intervals to assess health outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults diagnosed with pulmonary fibrosis who can engage with the home monitoring program.
Not a fit: Patients who cannot communicate in Dutch or lack internet access may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance patient self-management and improve health outcomes for those with pulmonary fibrosis.
How similar studies have performed: Other studies have shown promise in using home monitoring and telehealth approaches for chronic conditions, suggesting potential success for this method.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * A multidisciplinary ILD team diagnosis of pulmonary fibrosis according to ATS/ERS/JRS/ALAT guidelines; * Adults (=/\>18 years). Exclusion Criteria: * Patients who are not able to speak, read and/or write in Dutch; * Patients with no access to the internet; * Patients with a life expectancy of less than 1 year as determined by the treating healthcare provider; * Patients who are or have been using a home monitoring program for PF.
Where this trial is running
Amsterdam and 10 other locations
- Department of Pulmonology, Onze Lieve Vrouwe Gasthuis — Amsterdam, Netherlands (Recruiting)
- Department of Pulmonary Diseases, Rijnstate Hospital — Arnhem, Netherlands (Recruiting)
- Department of Respiratory Medicine, Amphia Hospital — Breda, Netherlands (Recruiting)
- Department of Respiratory Medicine, Catharina Hospital — Eindhoven, Netherlands (Recruiting)
- Department of Pulmonary Medicine, Zuyderland Medical Centre — Heerlen, Netherlands (Recruiting)
- Department of Pulmonology, Medical Center Leeuwarden — Leeuwarden, Netherlands (Recruiting)
- Department of Pulmonology, Leiden University Medical Center — Leiden, Netherlands (Recruiting)
- Interstitial Lung Diseases Center of Excellence, Department of Pulmonology, St Antonius Hospital — Nieuwegein, Netherlands (Recruiting)
- Department of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center — Rotterdam, Netherlands (Recruiting)
- Department of Pulmonology, Haaglanden Medisch Centrum — The Hague, Netherlands (Recruiting)
- Division of Heart and Lungs, University Medical Center Utrecht and Utrecht University — Utrecht, Netherlands (Recruiting)
Study contacts
- Principal investigator: Marlies S. Wijsenbeek-Lourens, Prof Dr — Department of Respiratory Medicine, Center of Excellence for Interstitial Lung Disease, Erasmus University Medical Center, Rotterdam, The Netherlands
- Study coordinator: Delian E. Hofman
- Email: d.hofman@erasmusmc.nl
- Phone: +31650162675
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.